TABLE I
Intensity of Antibody Binding in B10 Recombinant and Congenic Strain Origin of recombinants is detailed in reference 24 . + +, Bright; + -, dull; --, no staining.
D. Mathis (INSERM, CNRS, Strasbourg, France) . The Ek gene from this mouse was bred into the B10 .Q (H-2q) strain .
Flow Cytometry. The antibodies 14-4-4S and 17-3-3S (American Type Culture Collection, Rockville, MD) were purified by protein A from culture supernatant and biotinylated . PBL were isolated by Ficoll separation and stained with antibody at 4oC, followed by washing and labeling with streptoavidin-phycoerythrin at 4oC . A FACS IV (Becton Dickinson & Co., Mountain View, CA) was used to analyze the cells . Lymphocytes were gated on, using light scatter analysis, and resulting fluorescence is displayed on single fluorescence histograms.
The V011 antibody (RR3-15) and Vs6 antibody (44-22-1) were the kind gifts of Drs . Kanagawa (Lilly Research Laboratories, LaJolla, CA) and Hengartner (Institute ofPathology, University Hospital, Zurich, Switzerland) . They were used as culture supernatants diluted 1 :1 with buffer and incubated at 4oC with PBL. Cells were washed and stained with FITCconjugated mouse anti-rat IgG (Accurate Chemical & Scientific Corp., Westbury NY) . The cells were then washed and labeled with biotinylated antiThy-1.2 (Becton Dickinson & Co.) followed by streptavidin-phycoerythrin (Tago Inc., Burlingame, CA) . The FACS IV (Becton Dickinson & Co.) was again used and fluorescence intensities are displayed as dual-color counters . All dilutions and washes were done in PBS with 1% BSA (Sigma Chemical Co., St. Louis, MO) and 0.05% sodium azide.
MLC and Skin Grafts . 3 x 105 lymph node cells (LNC) were cultured with irradiated stimulator spleen cells as described earlier (15) . Means and SEM were calculated from triplicate cultures .
Skin grafts were performed as described earilier (16) . Briefly, tail skin from B10 .RQB3 was grafted on the back of B10 .RQB2 mice, and observed daily for signs of rejection .
Results
Ea Expression.
The Ea-specific mAb 14-4-4S (17) stained B10X PBL brightly. B10.M showed no labeling, while the recombinant strain B10.RFB2 with a nonexpressed Ef and a functional Ek showed low level E« expression (Fig. 1 A) . Strain B10.RFP with a functional E« also had similar levels of E« expression. Strain B10.RQB2 (E«-) showed no labeling, while B10 .RQB3 (Eq) gave low level of Ea expression (Fig. 1 B) . Both of these strains have nonfunctional E~chains, and differ only at the E« gene. The B10.Q;Ea transgenic mice confirmed these results . 
. Expression of Ea and Eo molecules labeled with 14-4-4 (En) and 17-3-3 (E f) . (A) H-2r recombinants ; (B) H-24 recombinants ; (C) Ea transgenics; (D) ES expression in recombinants.
molecule. PBLs were labeled with the E,o-specific antibody 17-3-3S (17) . Fig. 1 D shows 17-3-3 staining of B10X, but no detectable expression of ES was seen in B10.RFB2 or B10.RQB3. Table I summarizes the E« and E0 screening results. Clonal Deletion of TCR Vs11`T Cells. The percent of TCR V011 + T cells in the blood is shown in Table II . Bill et al . (6) have shown that the I-E molecule is necessary in the deletion of V011 + T cells. In B10.RFB2 the low level of Ea expression decreases the percentage of VS11 + T cells to -25% of that found in B10.M . Similarly, Ea+ B10.RQB3 shows approximately half the level of Vg11 + T cells compared with Ea-B10 .RQB2. B10.Q; Ea+ transgenic mice also had consistently lower levels of V011 cells while the Ea-full siblings were similar to the B10.Q parent .
Clonal Deletion of TCR VS6+ T Cells. TCR V06+ cells are clonally deleted in the context of Hs-la and I-A and/or I-E molecules. Fl crosses were made between DBA/1 (Mls-l a, I-E-) and strains of mice listed in Table 11 . DBA/1 (H-24) was chosen because it is I-E-and previously shown to have little influence on the donal deletion ofT cells reactive to Mis-la (19) . (DBA/1 x B10.RFB2)FZ expresses x+25% of the level ofVß6+ T cells compared with (DBA/1 x B10.M)Fl (Table II) Ea Molecule Is a Weak Alloantigm B10.RQB2 (E(x-) LNC responded well in an MLR to MHC differences (B10.K) but no significant response was seen against B10.RQB3 (Ea+) from the grafted or ungrafted mice (p > 0.01, data not shown) . B10.RQB3 tail skin, although rejected in 10-14 d when grafted onto B10X, was not rejected when grafted onto three B10.RQB2 mice after 50 d.
Discussion
FACS analysis has shown in vivo expression of the Ea molecule on the cell surface in I-Aa and I-Af recombinant mouse strains that do not express Eß . The possibility of low levels oftranscribed Eß carrying Ea to the cell surface was discounted by demonstrating the lack of binding of an Eß-specific antibody (17-3-3) in these strains. The observation that Ea is expressed in transgenic mice also confirms that Eß is not required for the Ea surface expression. Since Ea chain cannot be expressed on the membrane by itself, it must be pairing with the surface expression. The existence of an Ea + Aß hybrid molecule has recently been shown in a BALB/c lymphoma (20) . We were not able to pick up this hybrid molecule by immunoprecipitation . The low level of expression is presumably due to the very low affinity binding of Ea and Aß as compared with A a binding to Aß. Previous studies showing Ea chain expression have also acknowledged the possibility of low affinity binding, which prevents precipitation of the A0 chain with Ea in vivo (5, 15) . This hybrid molecule has not so far been detected in vivo in mice expressing Eß . The excess cytoplasmic Ea chain in strains lacking Eß may increase the association of Ea with Aß. Our results confirm in vivo previous studies done in vitro with transfected L cells and in B cell lymphomas.
The Ea + Aß hybrid molecule does function in vivo in cells expressing Vß6 and Vß11 TCRs. Both of these TCRs have been shown to require the involvement ofthe I-E molecule, in presentation of self antigens or in recognition of the I-E molecule . We have shown the Ea chain is significant in these processes.
The expression of Ea, however, does not lead to strong allorecognition in stimulating an MLR or in graft rejection. Previous studies have shown differences at the intact I-E molecule to be weakly antigenic in allograft rejection (21, 22) and to stimulate a moderate MLR (15) . The lower Ea expression in these recombinant mice compared with other I-E * strains might lead to the limited response. However, this seems unlikely since LPS-stimulated spleen cells with increased Ea expression are still not effective in stimulating a strong primary MLR (data not shown) . The allorecognition against an intact I-E molecule may be predominantly directed against the polymorphic Ea molecule while the E a molecule shows a great deal of homology between various haplotypes (23) . It is possible that the responder mice we used are tolerant to the Ea molecule or the T cells with highly I-E-reactive TCRs are missing, such as Vß17 (7). It will be interesting to see whether we can generate E"'-specific antibodies in this strain combination. We thank Dr. Benoist for the E,,, transgennc mice and Drs. Kanagawa, Palmer, and Hengartner for the Voll and V06 TCR antibodies. We also thank Julie Hansen for expert mouse husbandry; Suresh Savarirayan for generating the recombinant mice ; and Mary Brandt for skillful preparation of the manuscript .
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